Cisplatin-induced ototoxicity: Audiometric findings and experimental cochlear pathology

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Archives of oto-rhino-laryngology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00464398PMID 4041173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in the stria vascularis of the guinea pig due to cis-platinum

  2004cited by this paper
• The block-surface technique for evaluation of cochlear pathology

  2004cited by this paper
• Three-year results of combined modality therapy in locally advanced, resectable squamous cell carcinoma of the head and neck.

  1985cited by this paper
• cis-Diamminedichloroplatinum: a cytostatic with an ototoxic effect.

  1983cited by this paper
• Cis‐platinum Ototoxicity: Clinical experience and temporal bone histopathology

  1983cited by this paper
• Long‐term complications of radiotherapy confronting the head and neck surgeon

  1983cited by this paper
• Ototoxicity of the anticancer drug cisplatin. An experimental study.

  1982cited by this paper
• Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration.

  1982cited by this paper
• Inner ear histopathology in patients treated with Cis‐Platinum.

  1982cited by this paper
• The cortitoxic effects of cis-platinum in the guinea pig

  1982cited by this paper
• Cis-Diamminedichloroplatinum (II) Ototoxicity in the Guinea Pig

  1981cited by this paper
• Auditory toxicity effects of long‐term cis‐dichlorodiammineplatinum II therapy in genitourinary cancer patients

  1981cited by this paper
• cis-Platinum in gynecologic cancer. III. Toxicity.

  1981cited by this paper
• cis-Platinum in gynecologic cancer

  1981cited by this paper
• High dose Cis‐platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis

  1977cited by this paper
• Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pig.

  1975cited by this paper
• Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.

  1975cited by this paper

• Efficacy and Mechanisms of Antioxidant Compounds and Combinations Thereof against Cisplatin-Induced Hearing Loss in a Rat Model

  2024cites this paper
• The protective effect of aspirin-induced temporary threshold shift in an animal model of cisplatin-related ototoxicity

  2022cites this paper
• Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity

  2021cites this paper
• A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer

  2019cites this paper
• Cisplatin-induced threshold shift in the CBA/CaJ, C57BL/6J, BALB/cJ mouse models of hearing loss.

  2019cites this paper
• Chronotolerance for cisplatin ototoxicity in the rat

  2018cites this paper
• Drug-Induced Ototoxicity: Diagnosis and Monitoring

  2018cites this paper
• Long-Term Synergistic Interaction of Cisplatin- and Noise-Induced Hearing Losses

  2017cites this paper
• Pharmacokinetics and inner ear transport of cisplatin

  2015cites this paper
• Hearing Loss After Cisplatin: Oxidative Stress Pathways and Potential for Protection

  2015cites this paper
• Cisplatin otoprotection using transtympanic L‐N‐acetylcysteine: A pilot randomized study in head and neck cancer patients

  2014cites this paper
• Age-related hearing loss patterns in Fischer 344/NHsd rats with cisplatin-induced hearing loss.

  2013cites this paper
• An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect

  2013cites this paper
• Cisplatyna – lek z przypadku

  2012cites this paper
• The zebrafish as an in vivo model of drug-induced auditory and vestibular impairment

  2012cites this paper
• Mechanisms of Cisplatin Ototoxicity and Routes for Intervention

  2011cites this paper
• Cisplatin, a platinum-containing antineoplastic drug: perspectives on analytical chemistry and prevention of ototoxicity

  2010influential citation
• Distortion-Product Otoacoustic Emission Test Performance for Ototoxicity Monitoring

  2010cites this paper
• The use of otoacoustic emissions to predict ototoxic-induced hearing changes

  2009cites this paper
• Auditory late effects of chemotherapy.

  2009cites this paper
• Drug-Induced Hearing Loss

  2008cites this paper
• Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients

  2006cites this paper
• Evaluación de la ototoxicidad del cisplatino por el área bajo la curva audiométrica en retinoblastoma

  2006cites this paper
• Damage and threshold shift resulting from cochlear exposure to paraquat-generated superoxide.

  2005cites this paper
• Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model.

  2004cites this paper
• Ototoxic Protection of Sodium Thiosulfate: Daily vs Constant Infusion

  2004cites this paper
• Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis.

  2003cites this paper
• Emissões otoacústicas x Cisplatina: detecção precoce da ototoxicidade em pacientes oncológicos

  2003cites this paper
• Adverse drug reactions: When good chemicals go bad

  2003cites this paper
• Pifithrin-α supresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis

  2003cites this paper
• Strategies for Prevention of Toxicity Caused by Platinum‐Based Chemotherapy: Review and Summary of the Annual Meeting of the Blood–Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001

  2002cites this paper
• Carboplatin Induces Less Apoptosis in the Cochlea of Guinea Pigs than Cisplatin

  2002cites this paper
• Increases in spontaneous neural activity in the hamster dorsal cochlear nucleus following cisplatin treatment: a possible basis for cisplatin-induced tinnitus.

  2002cites this paper
• Antioxidant Therapy:A Promising Approach to the Prevention of Noise- and Drug-Induced Hearing Loss

  2002cites this paper
• Effects of difluoromethylornithine chemoprevention on audiometry thresholds and otoacoustic emissions.

  2001cites this paper
• Expression of inducible nitric oxide synthase (iNOS/NOS II) in the vestibule of guinea pigs after the application of cisplatin

  2000cites this paper
• Extended High-Frequency Ototoxicity Induced by the First Administration of Cisplatin

  2000cites this paper
• Cisplatin-induced ototoxicity: morphological evidence of spontaneous outer hair cell recovery in albino guinea pigs?

  2000cites this paper
• Cisplatin-induced Increases in Spontaneous Neural Activity in the Dorsal Cochlear Nucleus and Associated Outer Hair Cell Loss

  2000cites this paper
• Cisplatin ototoxicity in developing gerbils.

  1999cites this paper
• Cortical blindness as a manifestation of hypomagnesemia secondary to cisplatin therapy: case report and review of literature.

  1999cites this paper
• A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis.

  1998cites this paper
• Transient-Evoked Otoacoustic Emissions in Children after Cisplatin Chemotherapy

  1998cites this paper
• Endothelial injury of capillaries in the stria vascularis of guinea pigs treated with cisplatin and gentamicin.

  1997cites this paper
• Calcium supplementation and ototoxicity in patients receiving cisplatin.

  1996cites this paper
• Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer.

  1996cites this paper
• Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs.

  1995cites this paper
• Neuromuscular disorders in systemic malignancy and its treatment

  1995cites this paper
• Diet is a risk factor in cisplatin ototoxicity.

  1995cites this paper
• Comparative Adverse Effect Profiles of Platinum Drugs

  1995cites this paper
• Risk factors for ototoxicity due to cisplatin.

  1994cites this paper
• Subcellular localization of platinum in the guinea pig after treatment with cisplatin

  1994cites this paper
• Patterns of Hearing Loss Resulting from cis-Platinum Therapy

  1993cites this paper
• The “plateau effect” of cis-platinum–induced hearing loss

  1991cites this paper
• Cis‐platinum ototoxicity in children

  1991cites this paper
• Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administration.

  1991cites this paper
• Hearing loss--risk factor for cisplatin ototoxicity? Observations.

  1990cites this paper
• High‐Dose cisplatin treatment: Hearing loss and plasma concentrations

  1990cites this paper
• Ototoxicity of high‐dose cisplatin by bolus administration in patients with advanced cancers and normal hearing

  1988cites this paper
• Ototoxicity of cisplatin in gynaecological cancer patients.

  1988cites this paper
• Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis

  1988cites this paper
• Use of phase contrast microscopy to determine the height of the organ of Corti in whole-mount preparations.

  1987cites this paper